Menu

Important Document

Important Document

Sr. No. Title Details
101 Revised Guidelines for the Production Linked Incentive (PLI) Scheme for Promoting Domestic Manufacturing of Medical Devices
102 Required Modifications in the Guidelines of Production Linked Incentive Scheme for Promoting Domestic Manufacturing of Medical Devices (PLI MD) to invite applications for the eligible product as per Annexure-1A for Category-B applicant- reg.
103 Invitation of Applications from eligible Category-B Applicants under the Revised guidelines / corrigendum dt. 25 02.2023 of Production Linked Incentive (PLI) Scheme for Promoting Domestic Manufacturing of Medical Devices
104 Payment of Honorarium to Members of National Institutes of Pharmaceutical Education & Research (NIPER) Council - regarding
105 Guidelines for Hiring of Young Professionals (non-tech) on contract basis in the Department of Pharmaceuticals-reg.
106 Guidelines for Hiring of Non-Technical Consultants on contract basis in the Department of Pharmaceuticals-reg.
107 Guidelines for Hiring of Technical Consultants/Young Professionals (Tech.) on contract basis in the Department of Pharmaceuticals-regarding.
108 Modification of certain clauses of the PTUAS Sub-scheme of the Scheme 'Strengthening of Pharmaceuticals Industry'-regarding
109 Update on PLI for Bulk Drug as on 30.12.2022
110 Seeking Comments/views/suggestions from Stakeholders on Framing of Recruitment Rules for the post of Staff Car Driver in Department of Pharmaceuticals - reg
111 Extension of Timeline for Invitation of Applications from eligible Category B Applicants under the revised guidelines of PLI Scheme for Promoting Domestic Manufacturing of Medical Devices dated 18.8.2022 - till 21.11.2022- reg.
112 Amendment in the Operational Guidelines for the Production Linked Incentive (PLI) Scheme for Pharmaceuticals - reg
113 Extension of one week beyond 30.9.2022 for submission of application under the sub-scheme 'Assistance to Pharmaceutical Industry for Common Facilities (APICF)' - reg
114 Constitution of High Level Committee to consider various issues pertaining to UCPMP and examine the requirement for a legally enforceable mechanism for regulating marketing practices by Pharma Companies-regarding
115 Frequently Asked Questions (FAQs)- Pharmaceutical Technology Upgradation Assistance Scheme
116 Frequently Asked Questions (FAQs)- Assistance to Pharmaceutical Industry for Common Facilities (API-CF)
117 Amendment to the Order dated 21st January, 2019 with respect to constitution of Standing Committee on Affordable Medicines and Health Products (SCAMPH) - Regarding
118 14 सितम्बर, 2022 को हिन्दी दिवस के उपलक्ष्य में सचिव (औषध) का संदेश
119 Details of Applicants approved under Production Linked Incentive (PLI) Scheme for Pharmaceuticals
120 Message from Honorable Minister (C&F) on Swachhta Pakhwada During 1-15 September 2022
121 Message from Honorable MoS (C&F) on Swachhta Pakhwada During 1-15 September 2022
122 Invitation of Applications from eligible Category B Applicants under the revised guidelines of Production Link Incentive (PU) Scheme for Promoting Domestic Manufacturing of Medical Devices dated 18.8.2022 from 1st September 2022 to 31st October 2022 - reg
123 Corrigendum-Hiring of Young Professionals in the Department of Pharmaceuticals on contract basis.
124 Revised Guidelines for the Production Linked Incentive (PLI) Scheme for Promoting Domestic Manufacturing of Medical Devices
125 Hiring of Young Professionals in the Department of Pharmaceuticals on contract basis - regarding
126 List of Approved Applicants under Production Linked Incentive (PLI) Scheme for Bulk Drug Dated 8th August, 2022
127 Seeking the details of domestic manufacturers of the inputs required for manufacture of Vaccines and Biopharmaceuticals.
128 Corrigendum of PLI Scheme for Bulk Drug- Dated 26th July, 2022
129 Invitation of applications for the eligible product Vitamin B1,through chemical synthesis route under Production Linked Incentive (PLI) Scheme for Bulk Drug
130 Guidelines for the Scheme Strengthening of Pharmaceuticals Industry (SPI)- Notification of the modifications of the few clauses in the GLs - regarding
131 Filling up the post of Director (Finance) in Bengal Chemicals & Pharmaceuticals Ltd.(BCPL) through PESB selection mode.- regarding
132 O.M. dated 02.05.2022 to Central Procurement Agencies to exercise due diligence on the claims of the local manufacturers while proceeding for the procurement
133 Seeking comments/views/ suggestions from Stakeholders on Framing of Recruitment Rules for the post of Staff Car Driver in Department of Pharmaceuticals - reg
134 Guidelines on Pharmaceutical Innovation & Entrepreneurship
135 FAQs on the Invitation of Tender for selection of Public Financial Institution (Government Company) for providing services of Project Management Consultant (PMC) for the Scheme 'Strengthening of Pharmaceuticals Industry' (SPI)
136 Extension of timeline to submit proposal: Invitation of Tender for selection of Public Financial Institution (Government Company) for providing services of Project Management Consultant (PMC) for the Scheme Strengthening of Pharmaceuticals Industry (SPI)
137 Approval accorded to the States under the scheme 'Promotion of Medical Devices Park'
138 Awards to the leading Pharma and Medical Devices Industry playersIndia Pharma 2022 & India Medical Devices 2022-Extension of Date for invitation of Applications -reg
139 Annual Report 2021-22
140 Invitation of Applications for the posts of Director of NIPER- Ahmedabad and NIPER-Raebareli
141 Invitation of Applications under the PLI Scheme for Promotion of Domestic Manufacturing of critical Key Starting Materials(KSMs)/Drug Intermediates and Active Pharmaceuticals Ingredients (APIs) - extension till 30.04.2022
142 Notice: PPDS scheme for FY 21-22 - Selection of agencies for conducting studies (Long Term and Short Term) - reg.
143 Portal for India Pharma and India Medical Device Awards
144 Timeline Extension for filling applications under PLI Scheme for Promotion of Domestic Manufacturing of critical Key Starting Materials(KSMs)/Drug Intermediates and Active Pharmaceuticals Ingredients (APIs) upto 31.03.2022
145 Guidelines for the Scheme for Strengthening of Pharmaceuticals Industry (SPI)
146 Guidelines regarding Awards to the leading Pharma and Medical Devices Industry players - India Pharma 2022 & India Medical Devices 2022.
147 Notice regarding Awards to the leading Pharma and Medical Devices Industry players - India Pharma 2022 & India Medical Devices 2022
148 Public Notice dated 28.02.2022 :Inviting details of local manufacturers of specific Drugs -reg.
149 List of approved applicants under PLI Scheme for Bulk Drug (Dated :20-01-2021)
150 Public Notice dated 01.02.2022: Relaxation on Global Tender Enquiry (GTE) under Rule 161(iv) of General Financial Rules (GFRs) 2017 for procurement of Medical Devices - reg.

Pages